# APARNA ORGANICS LIMITED – FDA Inspection, Sep 12, 2023

Source: https://www.keypedia.com/records/fda_inspections/aparna-organics-limited/bd155553-3188-4b59-a51e-b84a6ce2ee6b
Source feed: FDA_Inspections

> FDA inspection 1222652 of APARNA ORGANICS LIMITED, September 12, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222652
- Company Name: APARNA ORGANICS LIMITED
- Inspection Date: 2023-09-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1086615 - 2019-03-15](https://www.keypedia.com/records/fda_inspections/aparna-organics-limited/4e97b0f0-df03-4367-8141-692c9941c291)
- [FDA Inspection 1047293 - 2018-04-06](https://www.keypedia.com/records/fda_inspections/aparna-organics-limited/7b282ee2-96d0-4f52-b260-9211b0fabee2)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)

Company: https://www.keypedia.com/companies/aparna-organics-limited/490be972-8080-4d97-a1f7-a704853a0323

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c